Balance Sheet
Cash Flow Statement
AmortizationAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dr Reddys Laboratories (RDY) Depreciation & Amortization (CF) (2017 - 2023)

Historic Depreciation & Amortization (CF) for Dr Reddys Laboratories (RDY) over the last 3 years, with Q1 2014 value amounting to $22.0.

  • Dr Reddys Laboratories' Depreciation & Amortization (CF) changed N/A to $22.0 in Q1 2014 from the same period last year, while for Dec 2014 it was $22.0, marking a year-over-year increase of 1000.0%. This contributed to the annual value of $200.0 million for FY2025, which is 1235.96% up from last year.
  • Dr Reddys Laboratories' Depreciation & Amortization (CF) amounted to $22.0 in Q1 2014.
  • Dr Reddys Laboratories' Depreciation & Amortization (CF)'s 5-year high stood at $22.0 during Q1 2014, with a 5-year trough of $18.0 in Q2 2012.
  • Moreover, its 3-year median value for Depreciation & Amortization (CF) was $20.0 (2013), whereas its average is $20.0.